These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 28323272

  • 1. Constipation-Predominant Irritable Bowel Syndrome Females Have Normal Colonic Barrier and Secretory Function.
    Peters SA, Edogawa S, Sundt WJ, Dyer RB, Dalenberg DA, Mazzone A, Singh RJ, Moses N, Smyrk TC, Weber C, Linden DR, MacNaughton WK, Turner JR, Camilleri M, Katzka DA, Farrugia G, Grover M.
    Am J Gastroenterol; 2017 Jun; 112(6):913-923. PubMed ID: 28323272
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The expression and the cellular distribution of the tight junction proteins are altered in irritable bowel syndrome patients with differences according to the disease subtype.
    Bertiaux-Vandaële N, Youmba SB, Belmonte L, Lecleire S, Antonietti M, Gourcerol G, Leroi AM, Déchelotte P, Ménard JF, Ducrotté P, Coëffier M.
    Am J Gastroenterol; 2011 Dec; 106(12):2165-73. PubMed ID: 22008894
    [Abstract] [Full Text] [Related]

  • 4. Duodenal Mucosal Barrier in Functional Dyspepsia.
    Puthanmadhom Narayanan S, O'Brien DR, Sharma M, Smyrk TC, Graham RP, Grover M, Bharucha AE.
    Clin Gastroenterol Hepatol; 2022 May; 20(5):1019-1028.e3. PubMed ID: 34607017
    [Abstract] [Full Text] [Related]

  • 5. Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators.
    Piche T, Barbara G, Aubert P, Bruley des Varannes S, Dainese R, Nano JL, Cremon C, Stanghellini V, De Giorgio R, Galmiche JP, Neunlist M.
    Gut; 2009 Feb; 58(2):196-201. PubMed ID: 18824556
    [Abstract] [Full Text] [Related]

  • 6. Serotonergic reinforcement of intestinal barrier function is impaired in irritable bowel syndrome.
    Keszthelyi D, Troost FJ, Jonkers DM, van Eijk HM, Lindsey PJ, Dekker J, Buurman WA, Masclee AA.
    Aliment Pharmacol Ther; 2014 Aug; 40(4):392-402. PubMed ID: 24943480
    [Abstract] [Full Text] [Related]

  • 7. Colonic mucosal gene expression and genotype in irritable bowel syndrome patients with normal or elevated fecal bile acid excretion.
    Camilleri M, Carlson P, Acosta A, Busciglio I.
    Am J Physiol Gastrointest Liver Physiol; 2015 Jul 01; 309(1):G10-20. PubMed ID: 25930081
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Mast cell tryptase reduces junctional adhesion molecule-A (JAM-A) expression in intestinal epithelial cells: implications for the mechanisms of barrier dysfunction in irritable bowel syndrome.
    Wilcz-Villega EM, McClean S, O'Sullivan MA.
    Am J Gastroenterol; 2013 Jul 01; 108(7):1140-51. PubMed ID: 23588236
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Multispecies probiotic protects gut barrier function in experimental models.
    Nébot-Vivinus M, Harkat C, Bzioueche H, Cartier C, Plichon-Dainese R, Moussa L, Eutamene H, Pishvaie D, Holowacz S, Seyrig C, Piche T, Theodorou V.
    World J Gastroenterol; 2014 Jun 14; 20(22):6832-43. PubMed ID: 24944474
    [Abstract] [Full Text] [Related]

  • 12. Differential mRNA Expression in Ileal Mucosal Biopsies of Patients With Diarrhea- or Constipation-Predominant Irritable Bowel Syndrome.
    Wang XJ, Carlson P, Chedid V, Maselli DB, Taylor AL, McKinzie S, Camilleri M.
    Clin Transl Gastroenterol; 2021 Apr 12; 12(4):e00329. PubMed ID: 33843785
    [Abstract] [Full Text] [Related]

  • 13. Development and Validation of Test for "Leaky Gut" Small Intestinal and Colonic Permeability Using Sugars in Healthy Adults.
    Khoshbin K, Khanna L, Maselli D, Atieh J, Breen-Lyles M, Arndt K, Rhoten D, Dyer RB, Singh RJ, Nayar S, Bjerkness S, Harmsen WS, Busciglio I, Camilleri M.
    Gastroenterology; 2021 Aug 12; 161(2):463-475.e13. PubMed ID: 33865841
    [Abstract] [Full Text] [Related]

  • 14. Urine sugars for in vivo gut permeability: validation and comparisons in irritable bowel syndrome-diarrhea and controls.
    Rao AS, Camilleri M, Eckert DJ, Busciglio I, Burton DD, Ryks M, Wong BS, Lamsam J, Singh R, Zinsmeister AR.
    Am J Physiol Gastrointest Liver Physiol; 2011 Nov 12; 301(5):G919-28. PubMed ID: 21836056
    [Abstract] [Full Text] [Related]

  • 15. A controlled trial of gluten-free diet in patients with irritable bowel syndrome-diarrhea: effects on bowel frequency and intestinal function.
    Vazquez-Roque MI, Camilleri M, Smyrk T, Murray JA, Marietta E, O'Neill J, Carlson P, Lamsam J, Janzow D, Eckert D, Burton D, Zinsmeister AR.
    Gastroenterology; 2013 May 12; 144(5):903-911.e3. PubMed ID: 23357715
    [Abstract] [Full Text] [Related]

  • 16. Serine proteases as luminal mediators of intestinal barrier dysfunction and symptom severity in IBS.
    Edogawa S, Edwinson AL, Peters SA, Chikkamenahalli LL, Sundt W, Graves S, Gurunathan SV, Breen-Lyles M, Johnson S, Dyer R, Graham R, Chen J, Kashyap P, Farrugia G, Grover M.
    Gut; 2020 Jan 12; 69(1):62-73. PubMed ID: 30923071
    [Abstract] [Full Text] [Related]

  • 17. Luminal cysteine-proteases degrade colonic tight junction structure and are responsible for abdominal pain in constipation-predominant IBS.
    Annaházi A, Ferrier L, Bézirard V, Lévêque M, Eutamène H, Ait-Belgnaoui A, Coëffier M, Ducrotté P, Róka R, Inczefi O, Gecse K, Rosztóczy A, Molnár T, Ringel-Kulka T, Ringel Y, Piche T, Theodorou V, Wittmann T, Bueno L.
    Am J Gastroenterol; 2013 Aug 12; 108(8):1322-31. PubMed ID: 23711626
    [Abstract] [Full Text] [Related]

  • 18. The Colonic Mucosal MicroRNAs, MicroRNA-219a-5p, and MicroRNA-338-3p Are Downregulated in Irritable Bowel Syndrome and Are Associated With Barrier Function and MAPK Signaling.
    Mahurkar-Joshi S, Rankin CR, Videlock EJ, Soroosh A, Verma A, Khandadash A, Iliopoulos D, Pothoulakis C, Mayer EA, Chang L.
    Gastroenterology; 2021 Jun 12; 160(7):2409-2422.e19. PubMed ID: 33617890
    [Abstract] [Full Text] [Related]

  • 19. Vasoactive Intestinal Polypeptide and Mast Cells Regulate Increased Passage of Colonic Bacteria in Patients With Irritable Bowel Syndrome.
    Bednarska O, Walter SA, Casado-Bedmar M, Ström M, Salvo-Romero E, Vicario M, Mayer EA, Keita ÅV.
    Gastroenterology; 2017 Oct 12; 153(4):948-960.e3. PubMed ID: 28711627
    [Abstract] [Full Text] [Related]

  • 20. [Changes of adherens junctions between the epithelial cells of intestinal mucosal barrier in irritable bowel syndrome].
    Chen CY, Zhang M, Wang SS, Lü B, Wang X.
    Zhonghua Yi Xue Za Zhi; 2017 Apr 11; 97(14):1065-1070. PubMed ID: 28395430
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.